• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌患者尿液中的表皮生长因子相关转化生长因子

Epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma.

作者信息

Chuang L Y, Tsai J H, Yeh Y C, Chang C C, Yeh H W, Guh J Y, Tsai J F

机构信息

Department of Biochemistry, Kaohsiung Medical College, Taiwan, Republic of China.

出版信息

Hepatology. 1991 Jun;13(6):1112-6.

PMID:1646759
Abstract

To characterize epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma, gel filtration with Bio-Gel P-30 was performed in seven hepatocellular carcinoma patients and seven sex-matched and age-matched healthy controls. Distinct profiles of soft agar growth assay in the hepatocellular carcinoma patients and the normal controls were seen. Three peaks (A, B and C) in the urine were examined. Peak C in most hepatocellular carcinoma patients was higher than that in healthy controls. Similar profiles were detected with epidermal growth factor radioreceptor assay and cellular DNA synthesis assay. This result might indicate that transforming growth factors with low molecular weight were found in the urine of hepatocellular carcinoma patients. An exceptional HCC patient had an additional peak (A') that corresponded to the high molecular weight protein. We concluded that there were transforming growth factors with functional activity in the urine of patients with hepatocellular carcinoma.

摘要

为了鉴定肝细胞癌患者尿液中与表皮生长因子相关的转化生长因子,对7例肝细胞癌患者以及7例性别和年龄匹配的健康对照者进行了Bio-Gel P-30凝胶过滤。在肝细胞癌患者和正常对照者中观察到了软琼脂生长试验的不同图谱。检测了尿液中的三个峰(A、B和C)。大多数肝细胞癌患者的C峰高于健康对照者。通过表皮生长因子放射受体测定和细胞DNA合成测定检测到了相似的图谱。这一结果可能表明在肝细胞癌患者的尿液中发现了低分子量的转化生长因子。一名特殊的肝癌患者有一个额外的峰(A'),它对应于高分子量蛋白质。我们得出结论,肝细胞癌患者的尿液中存在具有功能活性的转化生长因子。

相似文献

1
Epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma.肝细胞癌患者尿液中的表皮生长因子相关转化生长因子
Hepatology. 1991 Jun;13(6):1112-6.
2
Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Cancer Res. 1987 Feb 1;47(3):896-901.
3
Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.与正常个体相比,癌症患者尿液中转化生长因子活性的高效液相色谱图谱明显不同。
Cancer Res. 1984 Aug;44(8):3613-9.
4
Epidermal growth factor receptor in human hepatocellular carcinoma.
Cancer Detect Prev. 1997;21(4):355-60.
5
High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer.播散性癌症患者尿液中的高分子量转化生长因子活性。
Cancer Res. 1983 Jan;43(1):403-7.
6
Production of transforming growth factors by human colon cancer lines.人结肠癌细胞系转化生长因子的产生
Cancer Res. 1986 Mar;46(3):1164-9.
7
Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.肝细胞生长因子、转化生长因子α及其受体作为肝细胞癌预后的联合标志物
Mol Carcinog. 2003 Mar;36(3):130-41. doi: 10.1002/mc.10103.
8
Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.肿瘤形成中的尿转化生长因子:从人尿中分离125I标记的转化生长因子-α与表皮生长因子
Cancer Res. 1986 Nov;46(11):6004-10.
9
Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.纤维板层型肝细胞癌中表皮生长因子受体的表达及基因拷贝数
Hum Pathol. 2006 Apr;37(4):410-4. doi: 10.1016/j.humpath.2005.12.009.
10
Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.人脑肿瘤相关尿高分子量转化生长因子:一种高分子量形式的表皮生长因子。
Cancer Res. 1987 Feb 15;47(4):1190-6.

引用本文的文献

1
CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4-TGFα-EGFR signaling.环状 UCK2(2,3) 通过激活 CNIH4-TGFα-EGFR 信号通路促进癌症进展并增强乐伐替尼与 EGFR 抑制剂的协同细胞毒性。
Cell Mol Biol Lett. 2025 Jan 30;30(1):15. doi: 10.1186/s11658-025-00690-1.
2
Hepatocellular carcinoma: Review of disease and tumor biomarkers.肝细胞癌:疾病与肿瘤生物标志物综述
World J Hepatol. 2016 Apr 8;8(10):471-84. doi: 10.4254/wjh.v8.i10.471.
3
Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers.
肝癌的挑战:影像学和尿液生物标志物方面未来出现的工具
World J Hepatol. 2015 Nov 18;7(26):2664-75. doi: 10.4254/wjh.v7.i26.2664.
4
Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma.尿转化生长因子α和血清甲胎蛋白作为肝细胞癌的肿瘤标志物
Tumour Biol. 2014 Apr;35(4):3689-98. doi: 10.1007/s13277-013-1488-2. Epub 2013 Dec 30.
5
Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.尿转化生长因子-β1水平升高作为肝硬化肝细胞癌的肿瘤标志物及生存预后不良的预测指标
Br J Cancer. 1997;76(2):244-50. doi: 10.1038/bjc.1997.369.
6
Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.尿转化生长因子-β1和血清甲胎蛋白作为肝细胞癌肿瘤标志物的临床评估
Br J Cancer. 1997;75(10):1460-6. doi: 10.1038/bjc.1997.250.
7
Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.共表达c-myc和转化生长因子-α的转基因小鼠肝脏中肿瘤发生的演变
Am J Pathol. 1996 Aug;149(2):407-28.